Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Entellus Medical Inc
Leading provider of devices for minimally invasive sinus surgery
Transaction Summary
Revenue has increased rapidly to $59M run rate and 26% YoY growth
Completed IPO in January 2015 raising $78M
Well-positioned as an acquisition target; significant premiums paid as revenues approach ~$100M
Plymouth, MN
NASDAQ: ENTL
Contact:
Guido J. Neels
IPO
Acquisition
Acquired by: Stryker
Exit date: February 28, 2018
Related News
Entellus Medical Announces Collaboration with Fiagon
Entellus Medical Announces Positive 24 Month Data from Remodel Trial, Meta-Analysis Across 6 Studies
Entellus Medical Announces European Launch of XprESS (TM) LoProfile Multi-Sinus Dilation System
Entellus Medical Announces Promotion Of Robert White To Chief Executive Officer